Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Intra-aortic balloon pump after VA-ECMO reduces mortality in patients with cardiogenic shock: an analysis of the Chinese extracorporeal life support registry

Authors: Kexin Wang, Liangshan Wang, Jiawang Ma, Haixiu Xie, Chenglong Li, Xing Hao, Zhongtao Du, Hong Wang, Xiaotong Hou

Published in: Critical Care | Issue 1/2024

Login to get access

Abstract

Background

The role of intra-aortic balloon pump (IABP) combined with venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock (CS) remains unclear. This study investigated the effect of applying IABP for left ventricle (LV) unloading after VA-ECMO on reducing mortality in patients with CS.

Methods

Data from 5,492 consecutive patients with CS treated with VA-ECMO between January 2017 and July 2023 were collected from the CSECLS registry. The primary outcome was in-hospital mortality. The secondary outcomes included 30-day mortality, survival on VA-ECMO, and various complications. The association between the application of IABP after VA-ECMO and in-hospital outcomes was assessed.

Results

Among 5,492 patients undergoing VA-ECMO (mean age 54.7 ± 15.1 years, 3,917 [71.3%] male), 832 (15.1%) received IABP after VA-ECMO. Before VA-ECMO, a higher incidence of cardiac intervention (13.9% vs. 16.7%) and myocardial infarction (12.0% vs. 14.8%) (all P < 0.05) was seen in the IABP after VA-ECMO group. In this cohort, the IABP after VA-ECMO group had a lower in-hospital mortality (52.5% vs. 48.0%, P = 0.017) and a higher survival rate on VA-ECMO (75.4% vs. 79.4%, P = 0.014). On multivariate modeling, the use of IABP after VA-ECMO was associated with a lower risk of in-hospital mortality (adjusted odds ratio[aOR], 0.823 [95% confidence interval [CI], 0.686–0.987]; P = 0.035) and on-support mortality (aOR, 0.828 [95% CI, 0.688–0.995]; P = 0.044). However, the use of IABP after VA-ECMO was also associated with an increased incidence of complications, including mechanical (aOR: 1.905, [95% CI, 1.278–2.839]; P = 0.002), bleeding (aOR: 1.371, [95% CI, 1.092–1.721]; P = 0.007), renal (aOR: 1.252, [95% CI, 1.041–1.505]; P = 0.017), and pulmonary (aOR: 1.768, [95% CI, 1.446–2.163]; P < 0.001).

Conclusion

In this multicenter retrospective study, the use of IABP after VA-ECMO was associated with lower in-hospital mortality in patients with CS. These findings suggest that IABP may offer advantages for LV unloading in patients with CS treated with VA-ECMO, but further validation through randomized controlled trials is warranted to better understand the balance of risks and benefits.
Appendix
Available only for authorised users
Literature
4.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. https://doi.org/10.1093/eurheartj/ehw128.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. https://​doi.​org/​10.​1093/​eurheartj/​ehw128.CrossRefPubMed
6.
8.
go back to reference Aso S, Matsui H, Fushimi K, Yasunaga H. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med. 2016;44(11):1974–9.CrossRefPubMed Aso S, Matsui H, Fushimi K, Yasunaga H. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med. 2016;44(11):1974–9.CrossRefPubMed
11.
go back to reference Li Y, Yan S, Gao S, Liu M, Lou S, Liu G, et al. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis†. Eur J Cardio-thorac Surg Off J Eur Assoc Cardio-thorac Surg. 2019;55(3):395–404. https://doi.org/10.1093/ejcts/ezy304.CrossRef Li Y, Yan S, Gao S, Liu M, Lou S, Liu G, et al. Effect of an intra-aortic balloon pump with venoarterial extracorporeal membrane oxygenation on mortality of patients with cardiogenic shock: a systematic review and meta-analysis†. Eur J Cardio-thorac Surg Off J Eur Assoc Cardio-thorac Surg. 2019;55(3):395–404. https://​doi.​org/​10.​1093/​ejcts/​ezy304.CrossRef
20.
go back to reference Gass A, Palaniswamy C, Aronow WS, Kolte D, Khera S, Ahmad H, et al. Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology. 2014;129(3):137–43. https://doi.org/10.1159/000365138.CrossRefPubMed Gass A, Palaniswamy C, Aronow WS, Kolte D, Khera S, Ahmad H, et al. Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology. 2014;129(3):137–43. https://​doi.​org/​10.​1159/​000365138.CrossRefPubMed
22.
go back to reference Cheng R, Hachamovitch R, Makkar R, Ramzy D, Moriguchi JD, Arabia FA, et al. Lack of survival benefit found with use of intraaortic balloon pump in extracorporeal membrane oxygenation: a pooled experience of 1517 patients. J Invasive Cardiol. 2015;27(10):453–8.PubMed Cheng R, Hachamovitch R, Makkar R, Ramzy D, Moriguchi JD, Arabia FA, et al. Lack of survival benefit found with use of intraaortic balloon pump in extracorporeal membrane oxygenation: a pooled experience of 1517 patients. J Invasive Cardiol. 2015;27(10):453–8.PubMed
29.
go back to reference Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international. Multicent Cohort Stud Circ. 2020;142(22):2095–106. https://doi.org/10.1161/CIRCULATIONAHA.120.048792.CrossRef Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international. Multicent Cohort Stud Circ. 2020;142(22):2095–106. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​120.​048792.CrossRef
32.
go back to reference Pieri M, Sorrentino T, Oppizzi M, Melisurgo G, Lembo R, Colombo A, et al. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. J Interv Cardiol. 2018;31(6):717–24. https://doi.org/10.1111/joic.12569.CrossRefPubMed Pieri M, Sorrentino T, Oppizzi M, Melisurgo G, Lembo R, Colombo A, et al. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. J Interv Cardiol. 2018;31(6):717–24. https://​doi.​org/​10.​1111/​joic.​12569.CrossRefPubMed
Metadata
Title
Intra-aortic balloon pump after VA-ECMO reduces mortality in patients with cardiogenic shock: an analysis of the Chinese extracorporeal life support registry
Authors
Kexin Wang
Liangshan Wang
Jiawang Ma
Haixiu Xie
Chenglong Li
Xing Hao
Zhongtao Du
Hong Wang
Xiaotong Hou
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2024
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-024-05129-1